AMGN Jul 2023 195.000 put

OPR - OPR Prezzo differito. Valuta in USD.
1,0600
-0,4200 (-28,38%)
Al 03:59PM EDT. Mercato aperto.
Il grafico dei titoli non è supportato dal tuo browser attuale
Chiusura precedente1,4800
Aperto1,6600
Denaro0,9500
Lettera1,1800
Prezzo d'esercizio195,00
Scadenza2023-07-21
Min-Max giorno1,0200 - 1,6600
Contratto - Min-MaxN/D
Volume12
Open Interest164
  • GlobeNewswire

    Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

    Collaboration Brings Together TScan’s Proprietary Target Discovery Platform and Amgen’s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million THOUSAND OAKS, Calif. and WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan’s proprietary target discovery